cepharanthine has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Akhand, AA; Hayakawa, A; Hossain, K; Kato, M; Kurosawa, M; Liu, W; Nakashima, I; Suzuki, H; Takeuchi, K; Wu, J; Yoshihara, M; Zhou, YW | 1 |
Akhand, AA; Hossain, K; Nakashima, I; Suzuki, H; Wu, J; Zhou, YW | 1 |
3 other study(ies) available for cepharanthine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines.
Topics: Alkaloids; Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Benzylisoquinolines; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspases; Cysteine Proteinase Inhibitors; DNA Fragmentation; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Fusion Proteins, bcr-abl; Humans; Intracellular Membranes; Jurkat Cells; K562 Cells; Lactams, Macrocyclic; Lamin Type B; Lamins; Membrane Glycoproteins; Mitochondria; Neoplasm Proteins; Nuclear Proteins; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinones; Rifabutin | 2001 |
Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells.
Topics: Alkaloids; Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Caspase Inhibitors; Cysteine Proteinase Inhibitors; Enzyme Activation; Enzyme Inhibitors; Humans; Jurkat Cells; K562 Cells; Kinetics; Leukemia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein-Tyrosine Kinases; Transcription Factors | 2002 |